| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | +32.0% |
| Cost of Revenue | $1.8M | +16.2% |
| Gross Profit | $256K | +2744.4% |
| R&D Expense | $367K | +1083.9% |
| SG&A Expense | $3.2M | +27.0% |
| Operating Income | -$3.3M | -30.3% |
| Income Tax | $0 | — |
| Net Income | -$4.7M | -10.1% |
| EPS (Basic) | -$0.85 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $5.5M | — |
| Accounts Receivable | $222K | +6.2% |
| Inventory | $502K | +72.5% |
| Current Assets | $7.5M | -46.1% |
| Total Assets | $10.4M | -39.0% |
| Current Liabilities | $859K | -70.3% |
| Long-term Debt | $283K | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | -8.7% |
| Capital Expenditures | $96K | -64.3% |
| Investing Cash Flow | -$5.6M | -1979.9% |
| Financing Cash Flow | -$3.7M | -122.4% |
| Free Cash Flow | -$3.1M | -2.2% |
| +41.4% |
| Total Liabilities |
| $2.7M |
| -44.5% |
| Stockholders' Equity | $7.6M | -36.8% |